Annual Cash & Cash Equivalents
$13.36 M
+$3.74 M+38.80%
December 31, 2023
Summary
- As of February 8, 2025, INDP annual cash & cash equivalents is $13.36 million, with the most recent change of +$3.74 million (+38.80%) on December 31, 2023.
- During the last 3 years, INDP annual cash & cash equivalents has risen by +$11.72 million (+716.01%).
- INDP annual cash & cash equivalents is now -65.85% below its all-time high of $39.13 million, reached on December 31, 2021.
Performance
INDP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$7.38 M
+$78.90 K+1.08%
September 1, 2024
Summary
- As of February 8, 2025, INDP quarterly cash and cash equivalents is $7.38 million, with the most recent change of +$78.90 thousand (+1.08%) on September 1, 2024.
- Over the past year, INDP quarterly cash and cash equivalents has increased by +$78.90 thousand (+1.08%).
- INDP quarterly cash and cash equivalents is now -82.37% below its all-time high of $41.86 million, reached on September 30, 2021.
Performance
INDP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INDP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.8% | +1.1% |
| 3 y3 years | +716.0% | -41.9% |
| 5 y5 years | +716.0% | -41.9% |
INDP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.8% | +38.8% | -81.1% | +9.9% |
| 5 y | 5-year | -65.8% | +716.0% | -82.4% | +350.7% |
| alltime | all time | -65.8% | +716.0% | -82.4% | +350.7% |
Indaptus Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.38 M(+1.1%) |
| Jun 2024 | - | $7.30 M(-25.0%) |
| Mar 2024 | - | $9.74 M(-27.1%) |
| Dec 2023 | $13.36 M(+38.8%) | $13.36 M(-16.3%) |
| Sep 2023 | - | $15.96 M(+25.7%) |
| Jun 2023 | - | $12.70 M(+86.6%) |
| Mar 2023 | - | $6.81 M(-29.3%) |
| Dec 2022 | $9.63 M | $9.63 M(+43.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $6.72 M(-52.9%) |
| Jun 2022 | - | $14.26 M(-57.1%) |
| Mar 2022 | - | $33.22 M(-15.1%) |
| Dec 2021 | $39.13 M(+2289.8%) | $39.13 M(-6.5%) |
| Sep 2021 | - | $41.86 M(+146.3%) |
| Jun 2021 | - | $16.99 M(+937.6%) |
| Dec 2020 | $1.64 M | - |
| Dec 2020 | - | $1.64 M |
FAQ
- What is Indaptus Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Indaptus Therapeutics?
- What is Indaptus Therapeutics annual cash & cash equivalents year-on-year change?
- What is Indaptus Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Indaptus Therapeutics?
- What is Indaptus Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Indaptus Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of INDP is $13.36 M
What is the all time high annual cash & cash equivalents for Indaptus Therapeutics?
Indaptus Therapeutics all-time high annual cash & cash equivalents is $39.13 M
What is Indaptus Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, INDP annual cash & cash equivalents has changed by +$3.74 M (+38.80%)
What is Indaptus Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INDP is $7.38 M
What is the all time high quarterly cash and cash equivalents for Indaptus Therapeutics?
Indaptus Therapeutics all-time high quarterly cash and cash equivalents is $41.86 M
What is Indaptus Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, INDP quarterly cash and cash equivalents has changed by +$78.90 K (+1.08%)